| (11) | Registration Number: | P20250068 (Validated european patent) | |
| (21) | File number: | P20250068T |
| (22) | Date of filing the request: | 17.01.2025 |
| (45) | Patent Publication Date and Gazette Number: | 14.03.2025 |
| (54) | English Title: | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY |
| (96) | Number of the European patent application: | EP 20161276.9, 05.01.2018 | |
| (97) | Publication data of the European patent application: | EP 3722415, 14.10.2020, 202042, en | |
| (97) | Publication data of the European patent: | EP 3722415, 06.11.2024, 202445, en | |
| (51) | IPC: | C12N 5/0783 (2010.01) |
| | | C12M 1/04 (2006.01) |
| (73) | Holder(s): | | 1. | Iovance Biotherapeutics, Inc., 825 Industrial Road, Suite 400, San Carlos, CA 94070, US |
| |
| (72) | Inventor(s): | | 1. | Seth Wardell, 30204 USF Holly Drive, Tampa, FL 33620, US |
| |
| | | 2. | James Bender, 3 Cloverdale, Rancho Santa Margarita, CA 92688, US |
| |
| | | 3. | Michael T. Lotze, 5134 Westminster Place, Pittsburgh, PA 15232, US |
| |
| (74) | Representative: | ZMP IP d.o.o.,
Baruna Trenka 7, 10000 Zagreb, HR
|
| (30) | Priority Data: | | (31) | 201762596374 P | | (32) | 08.12.2017 | | (33) | US | | | 201762582874 P | | | 07.11.2017 | | | US | | | 201762577655 P | | | 26.10.2017 | | | US | | | 201762567121 P | | | 02.10.2017 | | | US | | | 201762559374 P | | | 15.09.2017 | | | US | | | 201762554538 P | | | 05.09.2017 | | | US | | | 201762548306 P | | | 21.08.2017 | | | US | | | 201762539410 P | | | 31.07.2017 | | | US | | | 201762478506 P | | | 29.03.2017 | | | US |
|
| (62) | Original Application Number and Date | EP18709132.7; 05.01.2018 | |
| (46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 14.03.2025 |
| | Annual fee: | 17.01.2025 for the 8th year | |
|
| |